Headquarters
LEVEL 3 62 LYGON STREET, CARLTON, Victoria 3053, AU
CARLTON, Victoria, AU
From the company
Immuron Limited is a commercial and clinical stage publicly listed Australian biopharmaceutical company that has pioneered an innovative platform technology focused on development and commercialization of a novel class of orally delivered polyclonal antibodies for enteric disease prevention and treatment. Founded and incorporated in Australia in 1994, it has been listed on the ASX since April 30, 1999 under the symbol IMC, and its ADSs and warrants are listed on NASDAQ under IMRN and IMRNW.
LEVEL 3 62 LYGON STREET, CARLTON, Victoria 3053, AU
Quantities, certifications, and timing.